SM
Sabby Management’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 18 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 30 |
|
|
2023
Q2 | – | Sell |
-65,714
| Closed | -$47.6K | – | 73 |
|
|
2023
Q1 | $47.6K | Sell |
65,714
-138,257
| -68% | -$100K | 0.04% | 63 |
|
|
2022
Q4 | $108K | Sell |
203,971
-207,925
| -50% | -$110K | 0.09% | 56 |
|
|
2022
Q3 | $343K | Sell |
411,896
-112,909
| -22% | -$94K | 0.43% | 38 |
|
|
2022
Q2 | $572K | Buy |
524,805
+162,733
| +45% | +$177K | 0.39% | 26 |
|
|
2022
Q1 | $453K | Buy |
+362,072
| New | +$453K | 0.07% | 38 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 109 |
|
|
2021
Q3 | – | Sell |
-1,045,987
| Closed | -$6.61M | – | 97 |
|
|
2021
Q2 | $6.61M | Buy |
1,045,987
+803,750
| +332% | +$5.08M | 0.93% | 5 |
|
|
2021
Q1 | $511K | Buy |
+242,237
| New | +$511K | 0.1% | 56 |
|
|
2019
Q1 | – | Sell |
-502,448
| Closed | -$513K | – | 58 |
|
|
2018
Q4 | $513K | Buy |
502,448
+37,409
| +8% | +$38.2K | 0.11% | 31 |
|
|
2018
Q3 | $814K | Buy |
465,039
+124,290
| +36% | +$218K | 0.1% | 27 |
|
|
2018
Q2 | $750K | Buy |
+340,749
| New | +$750K | 0.12% | 34 |
|
|
2017
Q3 | – | Sell |
-291,046
| Closed | -$150K | – | 88 |
|
|
2017
Q2 | $150K | Buy |
+291,046
| New | +$150K | 0.01% | 90 |
|